- Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: lebrikizumab; Drug: lebrikizumab; Drug: lebrikizumab; Drug: placebo
Sponsors: Genentech; Genentech
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Propranolol; Drug: Placebo; Drug: Qvar 50; Drug: Qvar 100
Sponsors: University of Dundee; University of Dundee; Chief Scientist Office of the Scottish Government
Not yet recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: FF/VI; Other: Existing Maintenance Therapy
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified May 2012 - Condition: Retinal Diseases
Interventions: Drug: GW824575; Drug: GW824575 matched-placebo
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Drug: inhaled steroid
Sponsors: Belfast Health and Social Care Trust; Liam Heaney; Northern Ireland Chest Heart & Stroke
Recruiting - verified February 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium+olodaterol; Drug: tiotropium + olodaterol (high dose); Drug: placebo to tiotropium+olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Allergy to Mold
Interventions: Other: Air Structuring Protein; Other: Placebo sorbet
Sponsors: Unilever SEAC; Unilever SEAC
Recruiting - verified December 2011 - Condition: Asthma
Interventions: Drug: QBX258; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: AIN457 (secukinumab); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Indacaterol Maleate (high dose; Form 1) and Placebo (Form 2); Drug: Placebo (Form 1) and Indacaterol Maleate (high dose; Form 2); Drug: Placebo (Form 1) and Indacaterol Maleate (low dose; Form 2); Drug: Placebo (Form 1) and Placebo (Form 2)
Sponsors: Novartis; Novartis
Recruiting - verified December 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide/Formoterol Fumarate; Drug: Aclidinium Bromide; Drug: Placebo; Drug: Formoterol Fumarate
Sponsors: Almirall, S.A.; Almirall, S.A.; Forest Laboratories
Recruiting - verified October 2011 - Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Salbutamol
Sponsors: Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; GlaxoSmithKline
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Zithromax; Drug: Placebo
Sponsors: Imperial College London; Imperial College London; National Institute for Health Research, United Kingdom
Not yet recruiting - verified September 2011 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Biological: MEDI8968 SC for 12 months; Biological: Placebo SC for 12 months
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: QAW039; Drug: Comparator leukotriene receptor antagonist (LRTA); Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Revamilast; Drug: Revamilast; Drug: Revamilast; Drug: Placebo
Sponsors: Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals Ltd. India; Glenmark Pharmaceuticals SA
Recruiting - verified January 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium + olodaterol; Drug: tiotropium; Drug: tiotropium; Drug: olodaterol
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Asthma
Intervention: Drug: Tralokinumab
Sponsors: MedImmune LLC; MedImmune LLC
Recruiting - verified January 2012 - Condition: Asthma
Interventions: Drug: 100 micrograms Fluticasone propionate; Drug: 500 micrograms Fluticasone propionate; Drug: lactose powder
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified January 2012 - Condition: Bronchial Asthma
Interventions: Drug: Keratinocyte Growth factor; Drug: Saline placebo
Sponsors: Southampton University Hospitals NHS Trust; Southampton University Hospitals NHS Trust
Recruiting - verified June 2010 - Condition: Obesity (BMI>30)
Intervention:
Sponsors: University of Oxford; University of Oxford
Recruiting - verified June 2011 - Conditions: Obesity; Obesity Hypoventilation Syndrome
Intervention:
Sponsors: Oxford University Hospitals NHS Trust; Oxford University Hospitals NHS Trust
Not yet recruiting - verified June 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: PH-797804; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Conditions: Persistent Cough; Whooping Cough
Interventions: Drug: Montelukast; Drug: Placebo
Sponsors: University of Oxford; University of Oxford
Recruiting - verified November 2011 - Conditions: COPD Method Evaluation; Chronic Obstructive Pulmonary Disease Method Evaluation
Interventions: Drug: Formoterol Turbuhaler; Drug: Budesonide/Formoterol Turbuhaler; Drug: Formoterol Turbuhaler
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Atimos®; Drug: Serevent™; Drug: Placebo
Sponsors: Chiesi Farmaceutici S.p.A.; Chiesi Farmaceutici S.p.A.
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Fixed dose combination salmeterol / fluticasone; Drug: Fixed-dose combination beclometasone dipropionate / formoterol
Sponsors: Research in Real-Life Ltd; Research in Real-Life Ltd; Chiesi Farmaceutici S.p.A.
Recruiting - verified June 2011 - Conditions: Asthma; Health
Intervention: Other: All patients
Sponsors: Centocor, Inc.; Centocor, Inc.
Recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Citalopram; Drug: Placebo
Sponsors: Belfast Health and Social Care Trust; Liam Heaney; Asthma UK
Recruiting - verified February 2012 - Condition: Asthma
Interventions: Drug: Ciclesonide; Drug: Placebo
Sponsors: University of Nottingham; University of Nottingham; Nottingham University Hospitals NHS Trust; University Hospitals, Leicester
Recruiting - verified January 2012 - Condition: Asthma
Intervention: Drug: Pioglitazone
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified November 2011 - Condition: Wheezing
Interventions: Drug: Mannitol; Drug: Montelukast
Sponsors: Queen Mary University of London; Queen Mary University of London; University of Aberdeen; University of Leicester
Recruiting - verified July 2011 - Condition: Scalp Psoriasis
Intervention: Drug: LEO 80185 (Xamiol® gel/Taclonex® Scalp topical suspension)
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified February 2012 - Condition: Stroke
Interventions: Drug: Transdermal glyceryl trinitrate patch; Drug: Pre-stroke antihypertensives
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified October 2011 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium +salmeterol+ fluticasone high dose; Drug: Tiotropium+salmeterol+ fluticasone high,med, low, placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Conditions: Deglutition Disorders; Esophageal Diseases; Eosinophilia
Intervention: Other: assessment of disease activity using the EEsAI
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; Institute of Social and Preventive Medicine, University Bern; Dept. of Gastroenterology, Kantonsspital Olten, Olten; Luzerner Kantonsspital; Mayo Clinic Rochester, Minnesota, USA; University of Cincinnati; University of Colorado, Denver; Northwestern University of Chicago, Illinois, USA; Indiana University School of Medicine; Philadelphia University
Recruiting - verified March 2012 - Condition: Asthma
Intervention: Other: bronchoscopy
Sponsors: Imperial College London; Imperial College London; Asthma UK; Royal Brompton & Harefield NHS Foundation Trust
Recruiting - verified June 2011 - Condition: Asthma
Intervention: Other: Fiberoptic bronchoscopy; blood test
Sponsors: Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Medical Research Council
Recruiting - verified June 2011 - Condition: Asthma
Intervention: Drug: prednisolone
Sponsors: Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust
Recruiting - verified June 2011 - Condition: Atopic Dermatitis
Intervention:
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified March 2012
 |
Join Clinical Trials in Tucson,Arizona |
